What India’s OTC boom means for pharma companies

Welcome to EY India Insights podcast!

In this episode, we explore how India’s over‑the‑counter (OTC) pharmaceutical market is transforming with rising self‑care awareness, the growth of digital commerce and ongoing gaps in healthcare accessibility.

Sumeet Chandna, Partner, Life Sciences, EY‑Parthenon India, discusses how evolving consumer behaviour is prompting pharma companies to rethink brand building, product formats and go‑to‑market strategies. He also highlights the need for a clearer OTC regulatory framework to enable simpler communication, unlock investments and strengthen long‑term trust.

Listen to our latest conversation on how India’s OTC boom is reshaping strategy and growth opportunities for pharma companies.

Subscribe to the EY India Insights Podcast for perspectives on business, finance, industry trends and global challenges.

Amazon podcasts | YouTube Music | Spotify